Sage Journals: Discover world-class research

Retricted access

Research article

First published 2006-06

Targeting of Biliary Cancer with Radiolabeled Chimeric Monoclonal Antibody CG250

Baudewijn W. Hendrickx, Cees J.A. Punt, Otto C. Boerman [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2004-04

PET Radioimmunoscintigraphy of Renal Cell Cancer Using 89 Zr-Labeled cG250 Monoclonal Antibody in Nude Rats

Adrienne Brouwers, Iris Verel, Julliëtte van Eerd [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2013-09

ImmunoPET Imaging of Renal Cell Carcinoma with 124 I- and 89 Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice

Alexander B. Stillebroer, Gerben M. Franssen, Peter F.A. Mulders [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Research article

First published 2013-2

Multimodal Imaging and Detection Strategy With 124 I-Labeled Chimeric Monoclonal Antibody cG250 for Accurate Localization and Confirmation of Extent of Disease During Laparoscopic and Open Surgical Resection of Clear Cell Renal Cell Carcinoma

Stephen P. Povoski, Nathan C. Hall, Douglas A. Murrey [...]

Surgical Innovation

Retricted access

Research article

First published 2004-08

Pharmacokinetics and Tumor Targeting of 131I-Labeled F(ab9)2 Fragments of the Chimeric Monoclonal Antibody G250: Preclinical and Clinical Pilot Studies

Adrienne Brouwers, Peter Mulders, Egbert Oosterwijk [...]

Cancer Biotherapy and Radiopharmaceuticals

Free access

Other

First published 2009-06

PET/CT imaging of clear cell renal cell carcinoma with 124I labeled chimeric antibody

Eamonn E. Bahnson, Douglas A. Murrey, Cathy M. Mojzisik [...]

Therapeutic Advances in Urology

Retricted access

Research article

First published 2013-1

Future Perspectives for Diagnostic Imaging in Urology: From Anatomic and Functional to Molecular Imaging

Giuseppe Macis, Silvia Di Giovanni, Davide Di Franco [...]

Urologia Journal

Retricted access

Research article

First published 2003-08

Biodistribution of 131 I-,186 Re-,177 Lu-,and 88 Y-Labeled hLL2 (Epratuzumab) in Nude Mice with CD22-Positive Lymphoma

Ernst J. Postema, Cathelijne Frielink, Wim J.G. Oyen [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results